CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology
CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology
Share
The IDE Pivotal Trial, MOCA-II, is intended to prospectively validate the diagnostic accuracy of the proprietary CorFlow CoFl system in determining the presence or absence of microvsacular obstruction (MVO) during a primary PCI procedure. The primary endpoint compares the CoFI diagnostic reading to a reference standard of diagnosis by a cardiac MRI scan. The trial is approved to enroll over 200 STEMI patients at prestigious research institutions in both the United States and Europe.
Having successfully completed the first-in-human MOCA-I trial in 2024, the MOCA-II study is the next critical step to bringing this unique technology into the hands of interventional cardiologists globally for the rapid diagnosis of MVO in heart attack patients. This in turn can enable new treatments and care pathways to the large MVO patient population with high rates of adverse clinical outcomes today. The CorFlow technology is designed to both diagnose MVO, plus serve as a localized drug delivery system for diagnostic and therapeutic agents, which is being researched independently.
According to the US government Centers for Disease Control and Prevention, someone has a heart attack every 30 seconds in the USA, with about 800,000 cases reported annually in the country. Incidence and prevalence are similarly high in Europe. More than half of STEMI heart attack patients are shown to have MVO, and previous research has demonstrated that the presence of MVO is a major driver of adverse events. Currently, there are no technologies approved to diagnose MVO during an acute coronary intervention, and there are no approved therapeutic devices that specifically address MVO in the United States or Europe. Heart attacks and related heart disease remains a leading cause of death and disability worldwide.
Paul Mead, CEO of CorFlow, said, 'The long history of interventional cardiology and heart attack care breakthroughs – going back over 100 years – is one of the great success stories of medical care progress, but the pioneers and luminaries of the field all agree that the work is unfinished. The majority of acute STEMI survivors have MVO, and current outcomes for these patients are shockingly poor. We aim to bring this issue to light and show you can do something about it. This milestone brings us all one step closer to delivering on the promise to improving care for these people where we know we can do better.'
MOCA-II is being led by world-renowned experts in heart attack care, Dr. Timothy Henry at The Christ Hospital in Cincinnati, Ohio (United States) and Professor Marco Valgimigli at Cardiocentro Ticino Institute, Lugano (Switzerland), who collectively have been published in over 1,000 peer-reviewed manuscripts in cardiovascular research.
Dr. Tim Henry said, 'As an interventional cardiologist involved for decades in managing and researching STEMI patients, I am excited to get going on this pivotal trial with technology that could make such a significant impact to the outcome of our patients. I believe strongly that knowing with high confidence who has MVO at the point of care during a primary PCI procedure can make an immediate difference in how we manage our patients.' Professor Valgimigli added, 'Having played a significant part in MOCA-I first in human trial, I am thrilled to see the second-generation technology now available for the pivotal trial and am looking forward to contributing further to the scientific understanding of MVO in real time. While the medical community has diverse opinions on how to treat these patients, there is no question that proper diagnosis is the first step we need. I am optimistic that getting the CorFlow technology approved for everyday use by our peer interventional cardiologists can help move the field forward.'
About CorFlow Therapeutics: Headquartered in Baar, Switzerland, with subsidiary operations in both Italy and the United States. The company is venture capital funded with an international VC firm syndicate, most recently with a Series B financing round announced in September 2024. CorFlow aspires to be the leader in diagnostic and therapeutic solutions for restoring healthy microvascular blood flow anywhere in the human body where a critical need exists. Working in close partnership with scientists from the University of Bern, ETH Zurich and the University Hospital Zurich, in a collaboration funded by the Swiss Innovation Agency (Innosuisse), CorFlow continues to explore applications for the unique patented technology.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
8 hours ago
- Business Upturn
The Pink Salt Trick Recipe for Fast Weight Loss Trend in 2025: Why ProZenith Is the Science-Backed Alternative
Chicago, July 19, 2025 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only. ProZenith is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA. Individual results may vary. Always consult a healthcare provider before beginning any supplement or diet strategy. Click Here to Explore the Full ProZenith Formula TL;DR: A trending pink salt recipe is sweeping TikTok as a supposed shortcut for weight loss. But what's really behind this viral drink, and why are experts raising concerns? In this report, we break down the trend's rise, the controversy around AI-generated celebrity endorsements, and how the new supplement ProZenith aims to support hormonal metabolism in a safer, research-backed way. In This Release, You'll Discover: What the 'Pink Salt Trick' recipe really is — and how it became a top 2025 TikTok trend Why AI-generated celebrity videos are being used to fuel misinformation The health risks of using saltwater as a weight loss tool What medical professionals and dietitians are saying about the trend Why women over 30 are most vulnerable to wellness misinformation How ProZenith compares biologically to salt-based hacks What makes ProZenith a better option for long-term metabolic balance Click Here to Learn More About ProZenith What Is the Pink Salt Trick Recipe Everyone's Talking About? The pink salt trick refers to a homemade drink recipe that's gone viral on TikTok and YouTube. It's typically presented as a 'weight loss drink' or 'morning metabolism hack' involving: The Recipe: 1/2 teaspoon pink Himalayan or Hawaiian salt Juice from 1/2 lemon 8–12 oz of warm or room temperature water Optional: 1 tsp apple cider vinegar or a dash of cayenne pepper The promise? Drink it first thing in the morning to 'reset metabolism,' suppress appetite, detox the body, and kickstart fat loss — without caffeine or fasting. Videos promoting the recipe often use phrases like: 'My pants are literally falling off!' 'This is what celebrities are using now.' 'Better than Ozempic!' But the science behind these claims is flimsy at best. And in many cases, entirely fabricated. Despite anecdotal praise, there are no peer-reviewed studies supporting the metabolic effects of pink salt water. Experts say any perceived benefits are likely due to placebo or temporary hydration effects, not real fat loss. The Deepfake Endorsement Controversy: Why the Internet Believed Oprah Promoted the Pink Salt Trick While the drink itself has gone viral, much of the attention in 2025 stems from AI-generated videos of Oprah Winfrey praising the recipe. These videos are so realistic that thousands believed they were real endorsements. In reality, Oprah never promoted the pink salt trick — and she condemned such deepfake scams in a 2022 Instagram video, stating: 'It is a fraud. It is a fake. It's a lie. I have nothing to do with any weight loss gummies or pink salt drinks that claim I use them.' Despite this, new videos using AI facial mapping and voice-cloning tools continue to circulate. Social media platforms have struggled to moderate these videos in real time, which has only contributed to their virality. This issue was spotlighted in Yahoo's creator series — What's Up with the Oprah Pink Salt Trick Recipe for Weight Loss? and What's the Deal with the Miracle Pink Salt Trick for Weight Loss? — where journalist Cassandra Brooklyn described how the fake endorsements kept showing up in her feed even though she never searched for weight loss tips. These articles were later mentioned in a broader industry discussion, including coverage in a GlobeNewswire consumer briefing on ProZenith. Read: Pink Salt Recipe for Weight Loss Spotlighted in New Consumer Briefing on Metabolic Reset with ProZenith Why the Pink Salt Trick Doesn't Work — and Might Be Harmful According to Dr. Alison Childress, a registered dietitian at Texas Tech University: 'Too much sodium can lead to water retention… this could result in weight gain — not fat, but fluid — especially in those who are salt-sensitive.' While the drink may provide a fleeting sense of fullness, there's no thermogenic benefit, hormonal regulation, or appetite suppression involved. Moreover, repeated use of this drink without iodine-rich salt can increase the risk of iodine deficiency, particularly among women of reproductive age. Iodine plays a critical role in thyroid hormone production, and inadequate levels can lead to fatigue, cold sensitivity, dry skin, and weight gain — all symptoms ironically counterproductive to the goals of the pink salt drink. Why Women Over 30 Are Most Vulnerable to These Trends Many women over 30 experience hormonal changes that affect metabolism, energy, and cravings. As stress levels increase and sleep quality declines, quick-fix trends feel even more attractive. Wellness journalist Cassandra Brooklyn explains: 'The pink salt videos started showing up in my feed even though I never searched for them. It made me wonder how many other women were seeing them too — especially those actively looking for help.' Research published in the International Journal of Behavioral Medicine shows that women exposed to 'rapid weight loss' messaging experienced higher body dissatisfaction and stress eating patterns. Compounding the issue is the algorithmic nature of social media, which can push diet content to vulnerable audiences based on a few clicks or likes. For women experiencing hormonal shifts and psychological stress, these seemingly innocent videos can drive harmful behaviors. Why ProZenith Was Formulated for This Exact Challenge ProZenith is a non-stimulant supplement formulated to help women manage appetite, cravings, and metabolic sluggishness without trendy hacks or viral gimmicks. What's Inside: Magnesium + Calcium – Regulate cortisol and stabilize energy – Regulate cortisol and stabilize energy BHB (Beta-Hydroxybutyrate) – Mimics ketone states to curb cravings – Mimics ketone states to curb cravings Turmeric Extract (95% curcuminoids) – Supports inflammation reduction – Supports inflammation reduction BioPerine® – Enhances nutrient absorption and delivery Unlike the pink salt trick, ProZenith doesn't rely on a placebo effect. Its ingredients have been clinically reviewed to support appetite hormones like ghrelin, reduce emotional eating triggers, and help restore metabolic rhythm in women after 30. Each dose is designed for consistency — not intensity. There are no stimulants, no crashes, and no 'flush' reactions. Just gradual, supportive metabolic regulation backed by emerging science and nutritional precision. Explore the Full Ingredient Breakdown Read: ProZenith Ingredients Researched: The Science Behind the Popular Formula Final Thoughts: Why This Trend Matters More Than It Seems The pink salt trick may look harmless. But it reflects a deeper pattern: emotional marketing, AI misinformation, and health shortcuts with no science behind them. ProZenith doesn't promise overnight results. But it does offer a research-supported daily strategy for women who are tired of fads and ready for clarity. If you're navigating hormonal shifts, emotional cravings, or just want to feel steady again — don't fall for digital hype disguised as healing. Support your body with something that respects biology. Click Here to Learn How ProZenith Works About the Brand ProZenith is a non-stimulant nutritional supplement designed to support women navigating hormonal appetite shifts, stress cravings, and metabolism slowdown. With clinically supported ingredients and zero caffeine, ProZenith offers a daily ritual for consistent metabolic support — without buzzwords, gimmicks, or fake endorsements. Customer Support ProZenith – Anti-Craving Support Without Stimulants Email: [email protected] Order Help: Phone (US): 1-800-390-6035 Phone (INT): 1-208-345-4245 Disclaimer This article is for informational purposes only. ProZenith is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA. Individual results may vary. Always consult a healthcare provider before beginning any supplement or diet strategy. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Yahoo
13 hours ago
- Yahoo
FDA Announces Major Recall of Popular Deodorant
It's important to stay informed about recalls, because doing so truly impacts your life. Of course, the sooner you know about a recall, the better, because you can make sure to get rid of the suspecting item and keep everyone in your family safe. "Recalls are important because they protect the public from products that may cause injury, illness or even death," the Food and Drug Administration notes. Now, a large number of Power Stick deodorants manufactured by A.P. Deauville are being recalled for manufacturing defects, according to the Food and Drug Administration. The recall includes more than 67,000 cases of roll-on deodorants that were sold across the United Stated, according to a notice posted by the agency. The problem with the deodorants revolves around deviations with "current good manufacturing practices," a set of guidelines in the pharmaceutical manufacturing industry. The recalled deodorants include the Power Stick for her roll-on Antiperspirant Deodorant Powder Fresh, 1.8 oz/53 mL; the Power Stick Invisible Protection Roll-On Antiperspirant Deodorant Spring Fresh, 1.8 oz/53 mL; and the Power Stick Original Nourishing Invisible Protection Roll-On Antiperspirant Deodorant, 1.8 oz/ 53 mL. Find specific lot numbers on the FDA's website. A press release has not been issued for the recall as of yet. The status of the recall is ongoing. According to the FDA, "A recall is an action taken by a company to correct or remove from the market an FDA regulated product that violates U.S. laws and regulations." They add that "recalls may be initiated voluntarily by a company, or at the request of the FDA." More than 83,000 FDA regulated products were recalled between the years 2014 and 2024. The FDA adds that "most recalls involve removing violative FDA regulated products from the market, but there are instances where a violation can be corrected without removing the products from distribution."FDA Announces Major Recall of Popular Deodorant first appeared on Men's Journal on Jul 19, 2025 Solve the daily Crossword
Indianapolis Star
15 hours ago
- Indianapolis Star
Man dies after being sucked into MRI machine by his own metal necklace
A man who was violently sucked into an MRI machine by a metal chain around his neck has died, police in New York said. The man was wearing a large metallic chain around his neck, which caused him to be drawn into the machine, the Nassau County Police Department said in a news release. The incident took place at the Nassau Open MRI medical facility in the village of Westbury on the North Shore of Long Island. Police responded to the facility just after 4:30 p.m. on July 16. At the scene, witnesses told officers a 61-year-old man "entered an unauthorized M.R.I. room while the scan was in progress," police said. Multiple injuries in incident: Over 2 dozen people injured after vehicle crashes into crowd in Los Angeles He was transported to a local hospital where he was initially listed in critical condition. He died at the hospital on July 17 at 2:36 p.m., police said. Officials have not yet released the name of the man nor whether he was a visitor to the facility, a patient or if he worked there. Police did not elaborate on the type or extent of the man's injuries. According to police, the machine's magnetic field immediately attracted "a large metallic chain" the victim wore, which quickly pulled him into the machine and "resulted in a medical episode." The investigation into the incident is ongoing, police said. USA TODAY contacted Nassau Open MRI on July 18 but has not received a response. Magnetic resonance imaging, or MRI, is a non-invasive 3D imaging technology used to examine patients' organs, tissues and skeletal system for diagnostic purposes, according to the Mayo Clinic. Adverse events from MRI scans "are rare," according to the U.S. Food and Drug Administration (FDA), which regulates MRI equipment. Millions of MRI scans are performed across the nation every year, the FDA wrote on its website. The agency said it receives around 300 incident reports annually involving MRI scanners and coils from manufacturers, distributors, user facilities and patients. Most of the reports, according to the FDA, include burns, as well as injuries from "projectile events" (objects being drawn toward the MRI scanner). High-powered magnets in the machine quickly draw items, especially metal, into the machine's chamber. "The strong magnetic field can attract metallic objects, potentially causing them to become projectiles and injure patients," the FDA's website reads.
